Exclusive-Probe of Musk's Neuralink to scrutinize long-criticized U.S animal welfare regulator


FILE PHOTO: Elon Musk arrives at the In America: An Anthology of Fashion themed Met Gala at the Metropolitan Museum of Art in New York City, New York, U.S., May 2, 2022. REUTERS/Andrew Kelly/File Photo

(Reuters) - Law enforcement officials investigating Elon Musk's Neuralink Corp over its animal trial program are also scrutinizing the U.S. Department of Agriculture’s oversight of the company's operations, after the agency failed to act on violations at other research organizations, according to several people familiar with the matter.

Reuters reported on Dec. 5 that the USDA's watchdog, the Office of the Inspector General, is investigating Neuralink, a medical device company that is developing brain implants, over potential animal-welfare violations. A federal prosecutor in the civil division at the U.S. Attorney’s Office for the Northern District of California requested the probe, people familiar with the matter said.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Tech News

X down for thousands of US users, Downdetector data finds
Musk says steps to stop Russia from using Starlink seem to have worked
French tech company Capgemini to sell US unit linked to ICE
Indonesia lets Elon Musk's Grok resume, lifting ban over sexualised images
I'm a parent, how worried should I be about AI?
Elon Musk's Grok generated 3 million sexualised images in just 11 days, new analysis finds
After robotaxi hits child, Waymo says its software prevented worse
Elon Musk says ‘singularity’ is here – What to know about AI threats to humanity
Waymo seeking about $16 billion near $110 billion valuation, Bloomberg News reports
Bitcoin falls below $80,000, continuing decline as liquidity worries mount

Others Also Read